Microbiome Sequencing Outsourcing Services Market Size, Share and Growth Outlook 2026: By Service Type, By Technology Platform, By Application Area, By End User, Companies to 2034
The global Microbiome Sequencing Outsourcing Services Market size is forecast to increase from $544.5 Million in 2026 to $1491.13 Million in 2034 at a CAGR of 13.42% between 2026 and 2034.
The Microbiome Sequencing Outsourcing Services market report provides detailed analysis and outlook of Microbiome Sequencing Outsourcing Services segments including By Service Type (16S rRNA Gene Sequencing, Shotgun Metagenomic Sequencing, Targeted Gene Panel Sequencing, Whole Genome and Metatranscriptomic Sequencing, Other Sequencing Services ), By Technology Platform (Sequencing-by-Synthesis (SBS), Sequencing-by-Ligation (SBL), Sanger Sequencing, Third-Generation / Long-Read Sequencing ), By Application Area (Gastrointestinal / Gut Microbiome Analysis, Oncology and Cancer Immunology, Infectious Disease and Vaginal/Urinary Microbiome, Skin and Oral Microbiome Analysis, Other Applications ), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Hospitals, Diagnostic Laboratories and Direct-to-Consumer (DTC) Providers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Microbiome Sequencing Outsourcing Services Industry Overview
Microbiome sequencing outsourcing is advancing from taxonomic profiling to high-resolution therapeutic support.
The microbiome sequencing outsourcing services industry is being reshaped by pharmaceutical demand for deeper microbial characterization, strain-level resolution, and clinically actionable multi-omic interpretation. Kanvas Biosciences’ $48 million Series A funding round, co-led by DCVC and Lions Capital LLC with participation from the Gates Foundation and other investors, highlights strong interest in specialized microbiome service platforms. The funding is intended to scale the company’s Kanvas Mapping platform, which provides high-resolution microbiome mapping services for pharmaceutical partners. Its capabilities in spatial transcriptomics and strain-level sequencing are directly aligned with live-biotherapeutic product development, where companies need to understand not only microbial identity but also localization, function, and interaction within biological systems.
Clinical trial outsourcing partners are becoming critical to regulatory-grade microbiome drug development.
CosmosID is strengthening its role as a microbial genomics and bioinformatics service provider by expanding clinical trial support infrastructure for microbiome-focused drug developers. The company’s service model centers on regulatory-grade, strain-level metagenomic sequencing and multi-omic data interpretation, enabling biotech firms to generate standardized evidence for microbiome-based therapeutics. Its pipelines are designed to support FDA submission requirements, making CosmosID an outsourced sequencing partner for companies that need validated workflows, reproducible analytics, and documentation-ready datasets. This reflects a broader industry requirement for sequencing service providers that can connect laboratory execution, bioinformatics quality, clinical trial endpoints, and regulatory expectations.
Functional omics is becoming the new competitive layer in outsourced microbiome workflows.
Leading microbiome contract research organizations are moving away from simple 16S rRNA gene profiling toward integrated functional omics services that provide mechanistic insight into microbial communities. Pharmaceutical companies are prioritizing microbial function over basic taxonomic identification, creating demand for outsourced pipelines that combine whole-genome shotgun sequencing, metatranscriptomics, and metabolomics. These workflows help characterize microbial activity, gene expression, metabolic output, and host-relevant biological effects in clinical trial subjects. For service providers, differentiation now depends on proprietary analytics, multi-omic integration, strain-level accuracy, clinical sample handling, and the ability to support live-biotherapeutic, biomarker, and precision medicine programs.
Microbiome Sequencing Outsourcing Services Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Microbiome Sequencing Outsourcing Services market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Illumina, Inc., Thermo Fisher Scientific Inc., BGI Genomics Co., Ltd., QIAGEN N.V., Eurofins Scientific, Novogene Co., Ltd., Zymo Research Corp., Clinical Microbiomics A/S, Macrogen, Inc., Agilent Technologies, Inc.. The Microbiome Sequencing Outsourcing Services market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Microbiome Sequencing Outsourcing Services industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Microbiome Sequencing Outsourcing Services industry include- Illumina, Inc., Thermo Fisher Scientific Inc., BGI Genomics Co., Ltd., QIAGEN N.V., Eurofins Scientific, Novogene Co., Ltd., Zymo Research Corp., Clinical Microbiomics A/S, Macrogen, Inc., Agilent Technologies, Inc.. The Microbiome Sequencing Outsourcing Services market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Microbiome Sequencing Outsourcing Services Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Microbiome Sequencing Outsourcing Services market remains one of the strongest-performing segments in the country.
The US Microbiome Sequencing Outsourcing Services Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Microbiome Sequencing Outsourcing Services market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Microbiome Sequencing Outsourcing Services industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Microbiome Sequencing Outsourcing Services markets
Canada's strong Microbiome Sequencing Outsourcing Services sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Microbiome Sequencing Outsourcing Services market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Microbiome Sequencing Outsourcing Services Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Microbiome Sequencing Outsourcing Services market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Microbiome Sequencing Outsourcing Services population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Microbiome Sequencing Outsourcing Services industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Microbiome Sequencing Outsourcing Services market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Microbiome Sequencing Outsourcing Services sales through 2034
France Microbiome Sequencing Outsourcing Services companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Microbiome Sequencing Outsourcing Services Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Microbiome Sequencing Outsourcing Services distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Microbiome Sequencing Outsourcing Services Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Microbiome Sequencing Outsourcing Services market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Microbiome Sequencing Outsourcing Services industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Microbiome Sequencing Outsourcing Services industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Microbiome Sequencing Outsourcing Services Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Microbiome Sequencing Outsourcing Services market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Microbiome Sequencing Outsourcing Services market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Microbiome Sequencing Outsourcing Services Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Microbiome Sequencing Outsourcing Services Market Segmentation
By Service Type
16S rRNA Gene Sequencing
Shotgun Metagenomic Sequencing
Targeted Gene Panel Sequencing
Whole Genome and Metatranscriptomic Sequencing
Other Sequencing Services
By Technology Platform
Sequencing-by-Synthesis (SBS)
Sequencing-by-Ligation (SBL)
Sanger Sequencing
Third-Generation / Long-Read Sequencing
By Application Area
Gastrointestinal / Gut Microbiome Analysis
Oncology and Cancer Immunology
Infectious Disease and Vaginal/Urinary Microbiome
Skin and Oral Microbiome Analysis
Other Applications
By End User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Research Organizations (CROs)
Hospitals, Diagnostic Laboratories and Direct-to-Consumer (DTC) Providers
Leading Companies in Microbiome Sequencing Outsourcing Services Industry (2026)
Illumina, Inc.
Thermo Fisher Scientific Inc.
BGI Genomics Co., Ltd.
QIAGEN N.V.
Eurofins Scientific
Novogene Co., Ltd.
Zymo Research Corp.
Clinical Microbiomics A/S
Macrogen, Inc.
Agilent Technologies, Inc.
Countries Included
The Microbiome Sequencing Outsourcing Services market report provides detailed analysis and outlook of Microbiome Sequencing Outsourcing Services segments including By Service Type (16S rRNA Gene Sequencing, Shotgun Metagenomic Sequencing, Targeted Gene Panel Sequencing, Whole Genome and Metatranscriptomic Sequencing, Other Sequencing Services ), By Technology Platform (Sequencing-by-Synthesis (SBS), Sequencing-by-Ligation (SBL), Sanger Sequencing, Third-Generation / Long-Read Sequencing ), By Application Area (Gastrointestinal / Gut Microbiome Analysis, Oncology and Cancer Immunology, Infectious Disease and Vaginal/Urinary Microbiome, Skin and Oral Microbiome Analysis, Other Applications ), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Hospitals, Diagnostic Laboratories and Direct-to-Consumer (DTC) Providers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Microbiome Sequencing Outsourcing Services Industry Overview
Microbiome sequencing outsourcing is advancing from taxonomic profiling to high-resolution therapeutic support.
The microbiome sequencing outsourcing services industry is being reshaped by pharmaceutical demand for deeper microbial characterization, strain-level resolution, and clinically actionable multi-omic interpretation. Kanvas Biosciences’ $48 million Series A funding round, co-led by DCVC and Lions Capital LLC with participation from the Gates Foundation and other investors, highlights strong interest in specialized microbiome service platforms. The funding is intended to scale the company’s Kanvas Mapping platform, which provides high-resolution microbiome mapping services for pharmaceutical partners. Its capabilities in spatial transcriptomics and strain-level sequencing are directly aligned with live-biotherapeutic product development, where companies need to understand not only microbial identity but also localization, function, and interaction within biological systems.
Clinical trial outsourcing partners are becoming critical to regulatory-grade microbiome drug development.
CosmosID is strengthening its role as a microbial genomics and bioinformatics service provider by expanding clinical trial support infrastructure for microbiome-focused drug developers. The company’s service model centers on regulatory-grade, strain-level metagenomic sequencing and multi-omic data interpretation, enabling biotech firms to generate standardized evidence for microbiome-based therapeutics. Its pipelines are designed to support FDA submission requirements, making CosmosID an outsourced sequencing partner for companies that need validated workflows, reproducible analytics, and documentation-ready datasets. This reflects a broader industry requirement for sequencing service providers that can connect laboratory execution, bioinformatics quality, clinical trial endpoints, and regulatory expectations.
Functional omics is becoming the new competitive layer in outsourced microbiome workflows.
Leading microbiome contract research organizations are moving away from simple 16S rRNA gene profiling toward integrated functional omics services that provide mechanistic insight into microbial communities. Pharmaceutical companies are prioritizing microbial function over basic taxonomic identification, creating demand for outsourced pipelines that combine whole-genome shotgun sequencing, metatranscriptomics, and metabolomics. These workflows help characterize microbial activity, gene expression, metabolic output, and host-relevant biological effects in clinical trial subjects. For service providers, differentiation now depends on proprietary analytics, multi-omic integration, strain-level accuracy, clinical sample handling, and the ability to support live-biotherapeutic, biomarker, and precision medicine programs.
Microbiome Sequencing Outsourcing Services Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Microbiome Sequencing Outsourcing Services market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Illumina, Inc., Thermo Fisher Scientific Inc., BGI Genomics Co., Ltd., QIAGEN N.V., Eurofins Scientific, Novogene Co., Ltd., Zymo Research Corp., Clinical Microbiomics A/S, Macrogen, Inc., Agilent Technologies, Inc.. The Microbiome Sequencing Outsourcing Services market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Microbiome Sequencing Outsourcing Services industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Microbiome Sequencing Outsourcing Services Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Microbiome Sequencing Outsourcing Services companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Microbiome Sequencing Outsourcing Services markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Microbiome Sequencing Outsourcing Services industry include- Illumina, Inc., Thermo Fisher Scientific Inc., BGI Genomics Co., Ltd., QIAGEN N.V., Eurofins Scientific, Novogene Co., Ltd., Zymo Research Corp., Clinical Microbiomics A/S, Macrogen, Inc., Agilent Technologies, Inc.. The Microbiome Sequencing Outsourcing Services market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Microbiome Sequencing Outsourcing Services Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Microbiome Sequencing Outsourcing Services market remains one of the strongest-performing segments in the country.
The US Microbiome Sequencing Outsourcing Services Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Microbiome Sequencing Outsourcing Services market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Microbiome Sequencing Outsourcing Services industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Microbiome Sequencing Outsourcing Services markets
Canada's strong Microbiome Sequencing Outsourcing Services sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Microbiome Sequencing Outsourcing Services market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Microbiome Sequencing Outsourcing Services Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Microbiome Sequencing Outsourcing Services market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Microbiome Sequencing Outsourcing Services population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Microbiome Sequencing Outsourcing Services industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Microbiome Sequencing Outsourcing Services market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Microbiome Sequencing Outsourcing Services sales through 2034
France Microbiome Sequencing Outsourcing Services companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Microbiome Sequencing Outsourcing Services Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Microbiome Sequencing Outsourcing Services distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Microbiome Sequencing Outsourcing Services Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Microbiome Sequencing Outsourcing Services market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Microbiome Sequencing Outsourcing Services industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Microbiome Sequencing Outsourcing Services industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Microbiome Sequencing Outsourcing Services Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Microbiome Sequencing Outsourcing Services market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Microbiome Sequencing Outsourcing Services market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Microbiome Sequencing Outsourcing Services Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Microbiome Sequencing Outsourcing Services Market Segmentation
By Service Type
16S rRNA Gene Sequencing
Shotgun Metagenomic Sequencing
Targeted Gene Panel Sequencing
Whole Genome and Metatranscriptomic Sequencing
Other Sequencing Services
By Technology Platform
Sequencing-by-Synthesis (SBS)
Sequencing-by-Ligation (SBL)
Sanger Sequencing
Third-Generation / Long-Read Sequencing
By Application Area
Gastrointestinal / Gut Microbiome Analysis
Oncology and Cancer Immunology
Infectious Disease and Vaginal/Urinary Microbiome
Skin and Oral Microbiome Analysis
Other Applications
By End User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Research Organizations (CROs)
Hospitals, Diagnostic Laboratories and Direct-to-Consumer (DTC) Providers
Leading Companies in Microbiome Sequencing Outsourcing Services Industry (2026)
Illumina, Inc.
Thermo Fisher Scientific Inc.
BGI Genomics Co., Ltd.
QIAGEN N.V.
Eurofins Scientific
Novogene Co., Ltd.
Zymo Research Corp.
Clinical Microbiomics A/S
Macrogen, Inc.
Agilent Technologies, Inc.
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Microbiome Sequencing Outsourcing Services Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Microbiome Sequencing Outsourcing Services Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Microbiome Sequencing Outsourcing Services Markets in 2026
3.2. Global Historic and Forecast Microbiome Sequencing Outsourcing Services Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Microbiome Sequencing Outsourcing Services Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Microbiome Sequencing Outsourcing Services Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Microbiome Sequencing Outsourcing Services Value Chain
CHAPTER 4- MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Microbiome Sequencing Outsourcing Services Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Service Type
16S RRNA GENE SEQUENCING
Shotgun Metagenomic Sequencing
Targeted Gene Panel Sequencing
Whole Genome and Metatranscriptomic Sequencing
Other Sequencing Services
By Technology Platform
Sequencing-by-Synthesis (SBS)
Sequencing-by-Ligation (SBL)
Sanger Sequencing
Third-Generation / Long-Read Sequencing
By Application Area
Gastrointestinal / Gut Microbiome Analysis
Oncology and Cancer Immunology
Infectious Disease and Vaginal/Urinary Microbiome
Skin and Oral Microbiome Analysis
Other Applications
By End User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Research Organizations (CROs)
Hospitals, Diagnostic Laboratories and Direct-to-Consumer (DTC) Providers
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Microbiome Sequencing Outsourcing Services Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Microbiome Sequencing Outsourcing Services Market Trends and Growth Opportunities to 2034
7.5. North America Microbiome Sequencing Outsourcing Services Market Size Outlook by Type
7.6. North America Microbiome Sequencing Outsourcing Services Market Size Outlook by Application
7.7. North America Microbiome Sequencing Outsourcing Services Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Microbiome Sequencing Outsourcing Services Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Microbiome Sequencing Outsourcing Services Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Microbiome Sequencing Outsourcing Services Companies
CHAPTER 8- EUROPE MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Microbiome Sequencing Outsourcing Services Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Microbiome Sequencing Outsourcing Services Market Trends and Growth Opportunities to 2034
8.5. Europe Microbiome Sequencing Outsourcing Services Market Size Outlook by Type
8.6. Europe Microbiome Sequencing Outsourcing Services Market Size Outlook by Application
8.7. Europe Microbiome Sequencing Outsourcing Services Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Microbiome Sequencing Outsourcing Services Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Microbiome Sequencing Outsourcing Services Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Microbiome Sequencing Outsourcing Services Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Microbiome Sequencing Outsourcing Services Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Microbiome Sequencing Outsourcing Services Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Microbiome Sequencing Outsourcing Services Companies
CHAPTER 9- ASIA PACIFIC MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Microbiome Sequencing Outsourcing Services Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Microbiome Sequencing Outsourcing Services Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Microbiome Sequencing Outsourcing Services Market Size Outlook by Type
9.6. Asia Pacific Microbiome Sequencing Outsourcing Services Market Size Outlook by Application
9.7. Asia Pacific Microbiome Sequencing Outsourcing Services Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Microbiome Sequencing Outsourcing Services Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Microbiome Sequencing Outsourcing Services Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Microbiome Sequencing Outsourcing Services Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Microbiome Sequencing Outsourcing Services Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Microbiome Sequencing Outsourcing Services Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Microbiome Sequencing Outsourcing Services Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Microbiome Sequencing Outsourcing Services Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Microbiome Sequencing Outsourcing Services Market Trends and Growth Opportunities to 2034
10.5. South and Central America Microbiome Sequencing Outsourcing Services Market Size Outlook by Type
10.6. South and Central America Microbiome Sequencing Outsourcing Services Market Size Outlook by Application
10.7. South and Central America Microbiome Sequencing Outsourcing Services Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Microbiome Sequencing Outsourcing Services Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Microbiome Sequencing Outsourcing Services Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Microbiome Sequencing Outsourcing Services Companies
CHAPTER 11- MIDDLE EAST AND AFRICA MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Microbiome Sequencing Outsourcing Services Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Microbiome Sequencing Outsourcing Services Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Microbiome Sequencing Outsourcing Services Market Size Outlook by Type
11.6. Middle East and Africa Microbiome Sequencing Outsourcing Services Market Size Outlook by Application
11.7. Middle East and Africa Microbiome Sequencing Outsourcing Services Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Microbiome Sequencing Outsourcing Services Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Microbiome Sequencing Outsourcing Services Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Microbiome Sequencing Outsourcing Services Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Microbiome Sequencing Outsourcing Services Industry
Illumina, Inc.
Thermo Fisher Scientific Inc.
BGI Genomics Co., Ltd.
QIAGEN N.V.
Eurofins Scientific
Novogene Co., Ltd.
Zymo Research Corp.
Clinical Microbiomics A/S
Macrogen, Inc.
Agilent Technologies, Inc.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Microbiome Sequencing Outsourcing Services Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Microbiome Sequencing Outsourcing Services Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Microbiome Sequencing Outsourcing Services Markets in 2026
3.2. Global Historic and Forecast Microbiome Sequencing Outsourcing Services Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Microbiome Sequencing Outsourcing Services Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Microbiome Sequencing Outsourcing Services Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Microbiome Sequencing Outsourcing Services Value Chain
CHAPTER 4- MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Microbiome Sequencing Outsourcing Services Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Service Type
16S RRNA GENE SEQUENCING
Shotgun Metagenomic Sequencing
Targeted Gene Panel Sequencing
Whole Genome and Metatranscriptomic Sequencing
Other Sequencing Services
By Technology Platform
Sequencing-by-Synthesis (SBS)
Sequencing-by-Ligation (SBL)
Sanger Sequencing
Third-Generation / Long-Read Sequencing
By Application Area
Gastrointestinal / Gut Microbiome Analysis
Oncology and Cancer Immunology
Infectious Disease and Vaginal/Urinary Microbiome
Skin and Oral Microbiome Analysis
Other Applications
By End User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Research Organizations (CROs)
Hospitals, Diagnostic Laboratories and Direct-to-Consumer (DTC) Providers
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Microbiome Sequencing Outsourcing Services Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Microbiome Sequencing Outsourcing Services Market Trends and Growth Opportunities to 2034
7.5. North America Microbiome Sequencing Outsourcing Services Market Size Outlook by Type
7.6. North America Microbiome Sequencing Outsourcing Services Market Size Outlook by Application
7.7. North America Microbiome Sequencing Outsourcing Services Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Microbiome Sequencing Outsourcing Services Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Microbiome Sequencing Outsourcing Services Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Microbiome Sequencing Outsourcing Services Companies
CHAPTER 8- EUROPE MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Microbiome Sequencing Outsourcing Services Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Microbiome Sequencing Outsourcing Services Market Trends and Growth Opportunities to 2034
8.5. Europe Microbiome Sequencing Outsourcing Services Market Size Outlook by Type
8.6. Europe Microbiome Sequencing Outsourcing Services Market Size Outlook by Application
8.7. Europe Microbiome Sequencing Outsourcing Services Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Microbiome Sequencing Outsourcing Services Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Microbiome Sequencing Outsourcing Services Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Microbiome Sequencing Outsourcing Services Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Microbiome Sequencing Outsourcing Services Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Microbiome Sequencing Outsourcing Services Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Microbiome Sequencing Outsourcing Services Companies
CHAPTER 9- ASIA PACIFIC MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Microbiome Sequencing Outsourcing Services Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Microbiome Sequencing Outsourcing Services Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Microbiome Sequencing Outsourcing Services Market Size Outlook by Type
9.6. Asia Pacific Microbiome Sequencing Outsourcing Services Market Size Outlook by Application
9.7. Asia Pacific Microbiome Sequencing Outsourcing Services Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Microbiome Sequencing Outsourcing Services Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Microbiome Sequencing Outsourcing Services Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Microbiome Sequencing Outsourcing Services Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Microbiome Sequencing Outsourcing Services Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Microbiome Sequencing Outsourcing Services Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Microbiome Sequencing Outsourcing Services Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Microbiome Sequencing Outsourcing Services Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Microbiome Sequencing Outsourcing Services Market Trends and Growth Opportunities to 2034
10.5. South and Central America Microbiome Sequencing Outsourcing Services Market Size Outlook by Type
10.6. South and Central America Microbiome Sequencing Outsourcing Services Market Size Outlook by Application
10.7. South and Central America Microbiome Sequencing Outsourcing Services Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Microbiome Sequencing Outsourcing Services Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Microbiome Sequencing Outsourcing Services Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Microbiome Sequencing Outsourcing Services Companies
CHAPTER 11- MIDDLE EAST AND AFRICA MICROBIOME SEQUENCING OUTSOURCING SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Microbiome Sequencing Outsourcing Services Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Microbiome Sequencing Outsourcing Services Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Microbiome Sequencing Outsourcing Services Market Size Outlook by Type
11.6. Middle East and Africa Microbiome Sequencing Outsourcing Services Market Size Outlook by Application
11.7. Middle East and Africa Microbiome Sequencing Outsourcing Services Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Microbiome Sequencing Outsourcing Services Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Microbiome Sequencing Outsourcing Services Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Microbiome Sequencing Outsourcing Services Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Microbiome Sequencing Outsourcing Services Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Microbiome Sequencing Outsourcing Services Industry
Illumina, Inc.
Thermo Fisher Scientific Inc.
BGI Genomics Co., Ltd.
QIAGEN N.V.
Eurofins Scientific
Novogene Co., Ltd.
Zymo Research Corp.
Clinical Microbiomics A/S
Macrogen, Inc.
Agilent Technologies, Inc.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
